Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willy Hugo

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Cancer Cell|January 21, 2015
Tunable-combinatorial mechanisms of acquired resistance limit the efficacy of BRAF/MEK cotargeting but result in melanoma drug addictionGatien Moriceau, Willy Hugo, Aayoung Hong, et al.
Cell|January 28, 2017
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic MelanomaWilly Hugo, Jesse M Zaretsky, Lu Sun, et al.
Cell|March 22, 2016
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic MelanomaWilly Hugo, Jesse M Zaretsky, Lu Sun, et al.
Cancer Discovery|September 3, 2017
Recurrent Tumor Cell-Intrinsic and -Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early AdaptationChunying Song, Marco Piva, Lu Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 2022
Pathogenic TNF-α drives peripheral nerve inflammation in an Aire-deficient model of autoimmunityYan Wang, Lily Guo, Xihui Yin, et al.
The Journal of Clinical Investigation|September 1, 2023
Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumorsLu Sun, Jenny C Kienzler, Jeremy G Reynoso, et al.
Nature Cell Biology|September 13, 2016
Regional glutamine deficiency in tumours promotes dedifferentiation through inhibition of histone demethylationMin Pan, Michael A Reid, Xazmin H Lowman, et al.
Nature Communications|December 16, 2014
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanomaJudith Müller, Oscar Krijgsman, Jennifer Tsoi, et al.
Cancer Discovery|November 23, 2013
Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapyHubing Shi, Willy Hugo, Xiangju Kong, et al.
Cell Reports|May 13, 2017
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 ExpressionAngel Garcia-Diaz, Daniel Sanghoon Shin, Blanca Homet Moreno, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Cancer Cell|January 21, 2015
Tunable-combinatorial mechanisms of acquired resistance limit the efficacy of BRAF/MEK cotargeting but result in melanoma drug addictionGatien Moriceau, Willy Hugo, Aayoung Hong, et al.
Cell|January 28, 2017
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic MelanomaWilly Hugo, Jesse M Zaretsky, Lu Sun, et al.
Cell|March 22, 2016
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic MelanomaWilly Hugo, Jesse M Zaretsky, Lu Sun, et al.
Cancer Discovery|September 3, 2017
Recurrent Tumor Cell-Intrinsic and -Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early AdaptationChunying Song, Marco Piva, Lu Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 2022
Pathogenic TNF-α drives peripheral nerve inflammation in an Aire-deficient model of autoimmunityYan Wang, Lily Guo, Xihui Yin, et al.
The Journal of Clinical Investigation|September 1, 2023
Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumorsLu Sun, Jenny C Kienzler, Jeremy G Reynoso, et al.
Nature Cell Biology|September 13, 2016
Regional glutamine deficiency in tumours promotes dedifferentiation through inhibition of histone demethylationMin Pan, Michael A Reid, Xazmin H Lowman, et al.
Nature Communications|December 16, 2014
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanomaJudith Müller, Oscar Krijgsman, Jennifer Tsoi, et al.
Cancer Discovery|November 23, 2013
Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapyHubing Shi, Willy Hugo, Xiangju Kong, et al.
Cell Reports|May 13, 2017
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 ExpressionAngel Garcia-Diaz, Daniel Sanghoon Shin, Blanca Homet Moreno, et al.
Pageof 6